Skip to main content
Byron Thomashow, MD, Pulmonology, New York, NY, New York-Presbyterian Hospital

ByronM.ThomashowMD

Pulmonology • New York, NY

Critical Care Medicine, Pleural Disease

Clinical Professor of Medicine, Columbia P&S

Join to view full profile

Dr. Thomashow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Thomashow's full profile

Already have an account?

Summary

  • Dr Byron Thomashow is a Professor of Medicine Columbia University Medical Center and an Attending Physician at the New York-Presbyterian Hospital. He helped found the COPD Foundation and served as Chairman of the Board of Directors for the last ten years. As of July 2018 he took on the role of Chief Medical Officer of the Foundation. He is the medical co-director of the Jo-Ann LeBuhn Center for Chest Disease on the Columbia campus and is medical director of the NewYork-Presbyterian Lung Volume Reduction program. He chaired the Respiratory Disease Council of the NewYork-Presbyterian Healthcare Network for many years. He is the co-chair for the NY State COPD Coalition, cochaired the New York State COPD Summit in 2010, co-chaired COPD7 USA 2011, COPD8USA 2013, COPD 9USA 2015, COPD10 USA 2017, and co-chaired the COPDFoundation COPD Readmission Summits in October 2013 and March 2015. The Byron M Thomashow Professorship of Medicine Columbia University was established in 2006. He was awarded the 2013 ATS Public Advisory Roundtable Excellence Award. In 2016 he received the Columbia University 2016 Leonard Tow Humanism in Medicine Award sponsored by the Arnold P. Gold Foundation. In 2017 he received the Albert Nelson Marquis Lifetime Achievement Award. In 2018 received the JWWalsh Visionary Award from the COPD Foundation.He was a member of the steering committee and the co-primary investigator at the Columbia site for the National Emphysema Treatment Trial and has been and remains actively involved in multiple national clinical research projects.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Pulmonary Disease, 1978 - 1979
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestFellowship, Pulmonary Disease and Critical Care Medicine, 1977 - 1978
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1974 - 1977
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1974

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 1975 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Can CAPTURE Be Used to Identify Undiagnosed Patients with Mild-to-Moderate COPD Likely to Benefit from Treatment?  
    Byron Thomashow, Randall W Brown, Stephen Rennard, Barbara P Yawn, David M Mannino, Barry J Make, MeiLan K Han, International Journal of Chronic Obstructive Pulmonary Disease

Press Mentions

  • PRE-PROOF Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation PRE-PROOF
    PRE-PROOF Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation PRE-PROOFDecember 22nd, 2022
  • Reckitt Collaborates with Leading Pulmonologists to Support Early Diagnosis of Chronic Chest Conditions
    Reckitt Collaborates with Leading Pulmonologists to Support Early Diagnosis of Chronic Chest ConditionsNovember 10th, 2022
  • Seventy Percent (70%) of Patients Surveyed Voice Concern About Tobacco Corporations’ Ownership of Lung Disease Treatments
    Seventy Percent (70%) of Patients Surveyed Voice Concern About Tobacco Corporations’ Ownership of Lung Disease TreatmentsAugust 15th, 2022
  • Join now to see all

Hospital Affiliations

Dr. Byron Thomashow, Dr. Byron Thomashow, MD, Dr. B Thomashow, Dr. Byron M. Thomashow